Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice.
暂无分享,去创建一个
[1] S. Sarkar,et al. Nicotine induces oxidative stress and activates nuclear transcription factor kappa B in rat mesencephalic cells , 2007, Molecular and Cellular Biochemistry.
[2] R. Homer,et al. IL-18 Is Induced and IL-18 Receptor α Plays a Critical Role in the Pathogenesis of Cigarette Smoke-Induced Pulmonary Emphysema and Inflammation1 , 2007, The Journal of Immunology.
[3] Carla M. T. Bauer,et al. Cigarette smoke impacts immune inflammatory responses to influenza in mice. , 2006, American journal of respiratory and critical care medicine.
[4] E. Domingo,et al. Impact of Protein Kinase PKR in Cell Biology: from Antiviral to Antiproliferative Action , 2006, Microbiology and Molecular Biology Reviews.
[5] S. Johnston,et al. How Viral Infections Cause Exacerbation of Airway Diseases , 2006, Chest.
[6] Stephan Gebel,et al. The kinetics of transcriptomic changes induced by cigarette smoke in rat lungs reveals a specific program of defense, inflammation, and circadian clock gene expression. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[7] D. Newcomb,et al. H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM‐1 and TLR3 expression , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[8] J. Hamilton,et al. Therapeutic potential of treating chronic obstructive pulmonary disease (COPD) by neutralising granulocyte macrophage-colony stimulating factor (GM-CSF). , 2006, Pharmacology & therapeutics.
[9] C. Coban,et al. Essential role of IPS-1 in innate immune responses against RNA viruses , 2006, The Journal of experimental medicine.
[10] Á. Zaballos,et al. Human Gene Profiling in Response to the Active Protein Kinase, Interferon-induced Serine/threonine Protein Kinase (PKR), in Infected Cells , 2006, Journal of Biological Chemistry.
[11] S. Johnston,et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. , 2006, American journal of respiratory and critical care medicine.
[12] Hong-Hsing Liu,et al. The specific and essential role of MAVS in antiviral innate immune responses. , 2006, Immunity.
[13] J. Wedzicha,et al. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.
[14] P. Coyle,et al. Human metapneumovirus in adults: a short case series , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[15] R. Stockley,et al. COPD exacerbations · 2: Aetiology , 2006, Thorax.
[16] G. Joos,et al. Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required? , 2005, Respiratory research.
[17] G. Donaldson,et al. Epidemiological relationships between the common cold and exacerbation frequency in COPD , 2005, European Respiratory Journal.
[18] T. Seemungal,et al. Airway and Systemic Inflammation and Decline in Lung Function in Patients With COPD , 2005, Chest.
[19] Min Q. Zhao,et al. Requirement for tumor necrosis factor-receptor 2 in alveolar chemokine expression depends upon the form of the ligand. , 2005, American journal of respiratory cell and molecular biology.
[20] R. Flavell,et al. Role of Cathepsin S-Dependent Epithelial Cell Apoptosis in IFN-γ-Induced Alveolar Remodeling and Pulmonary Emphysema1 , 2005, The Journal of Immunology.
[21] I. Petrache,et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice , 2005, Nature Medicine.
[22] N. Benowitz,et al. Cigarette smoking and infection. , 2004, Archives of internal medicine.
[23] E. R. Sutherland,et al. Management of chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[24] P. Paré,et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.
[25] M. Karin,et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4 , 2004, Nature.
[26] K. Aoshiba,et al. Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. , 2004, Chest.
[27] R. Hegele,et al. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. , 2003, The American journal of medicine.
[28] S. Hodge,et al. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells , 2003, Immunology and cell biology.
[29] K. Aoshiba,et al. Alveolar wall apoptosis causes lung destruction and emphysematous changes. , 2003, American journal of respiratory cell and molecular biology.
[30] T. Seemungal,et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease , 2002, Thorax.
[31] M. Sopori,et al. Effects of cigarette smoke on the immune system , 2002, Nature Reviews Immunology.
[32] T. Seemungal,et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[33] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[34] N. Anthonisen,et al. Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. , 2001, American journal of respiratory and critical care medicine.
[35] P. Hirth,et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.
[36] B. Ma,et al. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. , 2000, The Journal of clinical investigation.
[37] M. Gaxiola,et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. , 2000, Chest.
[38] T. Seemungal,et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations , 2000, Thorax.
[39] L. Fabbri,et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[40] S. Akira,et al. Cutting edge: generation of IL-18 receptor-deficient mice: evidence for IL-1 receptor-related protein as an essential IL-18 binding receptor. , 1999, Journal of immunology.
[41] S. Shapiro,et al. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. , 1997, Science.
[42] S. Der,et al. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] S. E. Brodie. New York, New York, USA , 1996 .
[44] A. Aguzzi,et al. Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase. , 1995, The EMBO journal.
[45] L. Fabbri,et al. Airway eosinophilia in chronic bronchitis during exacerbations. , 1994, American journal of respiratory and critical care medicine.
[46] A. Halbower,et al. Agarose infiltration improves morphology of cryostat sections of lung. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[47] Sheldon Cohen,et al. Smoking, alcohol consumption, and susceptibility to the common cold. , 1993, American journal of public health.
[48] A. Bradley,et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.
[49] J. Kark,et al. Cigarette smoking as a risk factor for epidemic a(h1n1) influenza in young men. , 1982, The New England journal of medicine.
[50] J. Kark,et al. Smoking and epidemic influenza-like illness in female military recruits: a brief survey. , 1981, American journal of public health.
[51] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .
[52] S. Johnston,et al. Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations. , 2007, Current pharmaceutical design.
[53] D. Hui,et al. A 1-year prospective study of the infectious etiology in patients hospitalized with acute exacerbations of COPD. , 2007, Chest.
[54] R. Schleimer. Innate immune responses and chronic obstructive pulmonary disease: "Terminator" or "Terminator 2"? , 2005, Proceedings of the American Thoracic Society.
[55] J. Wedzicha. Role of viruses in exacerbations of chronic obstructive pulmonary disease. , 2004, Proceedings of the American Thoracic Society.